CLINICAL_TRIALS ClinicalTrials.gov record update

High-Dose Erythropoietin in Very Low Birth Weight Infants for the Potential Treatment of Prematurity-Related Cerebral Hemorrhagic-Ischemic Injury: A Phase II Safety/Tolerability Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00589953
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:28.065113+00:00
Published At: 2013-07-30T00:00:00+00:00
Record Updated At: 2013-07-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infant, Premature", "Erythropoietin", "Brain Injury", "Intraventricular Hemorrhage", "Periventricular Leukomalacia", "Neurodevelopmental Outcomes", "Randomized Clinical Trial"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-07-30"
protocolSection.identificationModule.nctId: "NCT00589953"
protocolSection.identificationModule.officialTitle: "High-Dose Erythropoietin in Very Low Birth Weight Infants for the Potential Treatment of Prematurity-Related Cerebral Hemorrhagic-Ischemic Injury: A Phase II Safety/Tolerability Study"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.